Serological testing for CMV immunoglobulin M and G (IgM and IgG, respectively) is commonly used in immunocompetent persons to evaluate the possibility of whether CMV infection is contributing to the acute illness [2, 8, 9]. This evidence concerns the gene CD40LG and cytomegalovirus infection.